BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND FUS, P35637, 2521, ENSG00000089280, TLS/CHOP, FUS-CHOP, CHOP, FUS1, TLS AND Treatment
3240 results:

  • 1. Efficacy and safety of netupitant/palonosetron in preventing nausea and vomiting in diffuse large B cell lymphoma patients undergoing R-chop chemotherapy.
    Kwak K; Park Y; Kim BS; Kang KW
    Sci Rep; 2024 May; 14(1):11229. PubMed ID: 38755279
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Diffuse Large B-Cell lymphoma With Cardiac Invasion Presented as Acute Myocardial Infarction and Left Ventricular Hypertrophy: A Case Report.
    Liu Z; Pan X; Mo J; Deng T; Cen T; Wei B; Chen C
    J Investig Med High Impact Case Rep; 2024; 12():23247096241253334. PubMed ID: 38747509
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [The clinical features, survival analysis, and geriatric assessment of 85 patients with follicular lymphoma: a single-center study].
    Yin JJ; Qian L; Bai JF; Feng R; Li JT; Wang T; Zhang CL; Liu H
    Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):233-241. PubMed ID: 38716594
    [No Abstract]    [Full Text] [Related]  

  • 4. Real-world total cost of care by line of therapy in relapsed/refractory diffuse large B-cell lymphoma.
    Gatwood J; Masaquel A; Fox D; Sheinson D; James C; Li J; Hossain F; Ross R
    J Med Econ; 2024; 27(1):738-745. PubMed ID: 38686393
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The Impact of Tumor Hypoxia Modulation on sIL-2R Levels in Newly Diagnosed Diffuse Large B Cell lymphoma (DLBCL) Patients Undergoing Chemotherapy: A Randomized Clinical Trial.
    Rizky D; Tandarto K; Pangarsa EA; Naibaho RM; Kurniawan SP; Santosa D; Setiawan B; Suharti C
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1315-1324. PubMed ID: 38679992
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus-associated mantle cell lymphoma.
    Feng J; Fei Y; Gao M; Meng X; Zeng D; Zou D; Ye H; Liang Y; Sun X; Liang R; Zhou H; Wang X; Zhang H
    Hematol Oncol; 2024 May; 42(3):e3268. PubMed ID: 38676394
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Experience of multi-disciplinary treatment of multiple cerebellar diffuse large B-cell lymphoma: A case report.
    Guo Y; Li J; Li M; Li Z; Cui Y; Li Y; Zhao R; Han Q; Yang H; Ma C
    Medicine (Baltimore); 2024 Apr; 103(17):e37923. PubMed ID: 38669361
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Real-world patient characteristics, treatment patterns, and treatment outcomes of patients with diffuse large B-cell lymphoma by line of therapy.
    Sineshaw HM; Zettler CM; Prescott J; Garg M; Chakraborty S; Sarpong EM; Bai C; Belli AJ; Fernandes LL; Wang CK
    Cancer Med; 2024 Apr; 13(7):e7173. PubMed ID: 38597118
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first-line treatment: A 15-year follow-up of patients with advanced follicular lymphoma in JCOG0203.
    Watanabe T; Matsuno Y; Wakabayashi M; Maruyama D; Yamamoto K; Kubota N; Shimada K; Asagoe K; Yamaguchi M; Ando K; Ogura M; Kuroda J; Suehiro Y; Tsukasaki K; Tobinai K; Nagai H
    Hematol Oncol; 2024 May; 42(3):e3272. PubMed ID: 38595316
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Role of plasma EBV-DNA load and EBER status on newly diagnosed peripheral T-cell lymphoma.
    Chen J; Zhou J; Cheng F; Chen D; Guan F; Zhang E; He J; Cai Z; Zhao Y
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):181. PubMed ID: 38587664
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prediction of immunochemotherapy response for diffuse large B-cell lymphoma using artificial intelligence digital pathology.
    Lee JH; Song GY; Lee J; Kang SR; Moon KM; Choi YD; Shen J; Noh MG; Yang DH
    J Pathol Clin Res; 2024 May; 10(3):e12370. PubMed ID: 38584594
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Successful bridging therapy with alectinib prior to allogeneic stem cell transplantation for refractory ALK-positive anaplastic large cell lymphoma].
    Kono A; Tanaka K; Shimada T; Bando K; Takahata A; Koi S; Yamamoto M; Mori T; Toyota S
    Rinsho Ketsueki; 2024; 65(3):158-163. PubMed ID: 38569859
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia.
    Hampel PJ; Swaminathan M; Rogers KA; Parry EM; Burger JA; Davids MS; Ding W; Ferrajoli A; Hyak JM; Jain N; Kenderian SS; Wang Y; Wierda WG; Woyach JA; Parikh SA; Thompson PA
    Blood Adv; 2024 May; 8(10):2342-2350. PubMed ID: 38537065
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Spontaneous tumor lysis syndrome (Stls) during biopsy for burkitt lymphoma: a case report.
    Pan S; Shen Q; Zhou J; Li T
    BMC Pediatr; 2024 Mar; 24(1):209. PubMed ID: 38521927
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Primary adrenal lymphoma presenting as neurolymphomatosis: A case report.
    Chen Z; Lin L; Xu L; Lin R; Jiang X
    Medicine (Baltimore); 2024 Mar; 103(12):e37558. PubMed ID: 38518055
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Ferroptosis mechanisms and its novel potential therapeutic targets for DLBCL.
    Bian W; Li H; Chen Y; Yu Y; Lei G; Yang X; Li S; Chen X; Li H; Yang J; Yang C; Li Y; Zhou Y
    Biomed Pharmacother; 2024 Apr; 173():116386. PubMed ID: 38492438
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A single-centre, real-world study of BTK inhibitors for the initial treatment of MYD88
    Deng T; Zhang S; Xiao M; Gu J; Huang L; Zhou X
    Cancer Med; 2024 Feb; 13(4):e7005. PubMed ID: 38457222
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Primary thyroid lymphoma: a case series.
    Sakhri S; Zemni I; Ayadi MA; Kamoun S; Chargui R; Ben Dhiab T
    J Med Case Rep; 2024 Feb; 18(1):108. PubMed ID: 38395921
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Compression therapy using surgical gloves is ineffective for the prevention of vincristine-induced neuropathy in patients with malignant lymphoma.
    Suyama T; Tsuboi Y; Shimizu M; Kuroda A; Seki M; Shinagawa A
    Support Care Cancer; 2024 Feb; 32(3):173. PubMed ID: 38378914
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Looking to achieve cure the first time around for DLBCL patients who are older and/or with co-morbidities.
    Brem EA; Sehn LH
    Semin Hematol; 2023 Nov; 60(5):285-290. PubMed ID: 38368147
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 162.